Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Coexistence of primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) is referred to as PBC‐AIH overlap. Pathogenesis of PBC‐AIH is not well understood and its diagnosis is challenging. We previously reported the clinical characteristics of 10 patients diagnosed with PBC‐AIH overlap. Aims: The aim of the study was extend the earlier series and evaluate the diagnostic criteria, biological characteristics, potential therapy, and long‐term outcomes of patients with PBC‐AIH overlap. Methods and Results: We retrospectively analyzed clinical, biochemical, and histological characteristics of 144 patients diagnosed with PBC and 73 diagnosed with AIH. We identified 16 cases of PBC‐AIH overlap, according to criteria established by Chazouillères et al. and other studies. PBC preceded AIH in 6 patients and both diseases occurred simultaneously in the remaining 10 patients. PBC‐AIH overlap has clinical, biochemical, and histological characteristics of both PBC and AIH. Thirteen patients treated with both ursodeoxycholic acid (UDCA) and immunosuppressive therapy responded well, with normal alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels. The remaining three patients treated with either prednisolone (PSL) or UDCA alone developed cirrhosis, varices, ascites, encephalopathy, or died of liver‐related causes at the 5, 12, and 14‐year follow up. Conclusions: PBC‐AIH overlap is not a rare entity; it was observed in 11% of PBC patients in this study. Further studies will be required to investigate whether PBC‐AIH overlap is distinct from the two individual diseases in terms of long‐term outcomes and therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746 · cited 6×
“criteria.(4) Both of these diagnostic criteria avoid the aforementioned drawback and have thus been used in most recent studies.”
BackgroundMethodResultInfluentialPoupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Autoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189 · cited 8×
“All sixteen patients diagnosed with PBC-AIH overlap according to the Chazouillères et al. criteria were also evaluated by the separate criteria for PBC and AIH.”
BackgroundInfluentialJoshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology · doi:10.1053/jhep.2002.30902 · Cited by 174 · cited 10×
“reported that response to UDCA therapy in patients with strictly defined PBC-AIH overlap was similar to that of patients with PBC.(6) Some investigators have reported that immunosuppressive therapy is useful when UDCA therapy is ineffective(4,8) while others have suggested that combination therapy would be more effect…”
BackgroundMethodResultInfluentialDegott, C., Zafrani, E. S., Callard, P., Balkau, B., Poupon, R. E., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290444 · Cited by 174
Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes
Silveira, M. G., Talwalkar, J. A., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01136.x · Cited by 165 · cited 3×
“Additionally, a previous study indicated that patients with PBC and features of AIH overlap had a higher risk of symptomatic portal hypertension and worse outcomes compared to those with PBC alone.(13) Therefore, distinguishing between patients with PBC-AIH overlap and patients with PBC or AIH alone is important becau…”
BackgroundResultInfluentialTalwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05703.x · Cited by 127
Cited by
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis
Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A., & Lindor, K. D. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132337 · Cited by 47
Harada, K., Hsu, M., Ikeda, H., Zeniya, M., & Nakanuma, Y. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31827234e4 · Cited by 46
“PBC and AIH are both autoimmune diseases, which selectively affect cholangiocytes and hepatocytes, respectively, but PBC-AIH overlap or the hepatitic-form of PBC also has been recognized.(17,18) Because our grading system can independently evaluate cholangitis and hepatitis, this system is very useful in evaluating th…”
BackgroundLiu, F., Pan, Z. G., Ye, J., Xu, D., Guo, H., Li, G. P., Xu, K. S., Hou, X. H., & Song, Y. H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12196 · Cited by 23
Zhang, H., Li, S., Yang, J., Zheng, Y., Wang, J., Lu, W., Zhou, Y., Yin, Q., Zhu, R., & Guo, C. (2015) · Gastroenterology Review · doi:10.5114/pg.2015.51187 · Cited by 17
“In 2009, the EASL guidelines also advised that UDCA therapy should be administered for 3 months, and if the biochemical response is poor, corticosteroids combination therapy can be added [27, 28].”
Method
Metadata
- Authors
- Yokokawa, J., Saito, H., Kanno, Y., Honma, F., Monoe, K., Sakamoto, N., Abe, K., Takahashi, A., Yokokawa, H., & Ohira, H.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2010-01-28
- Volume
- 25
- Issue
- 2
- Pages
- 376-382
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2064456250
- Cited by
- 45
- References
- 12
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. https://app.cochat.ai/papers/10.1111/j.1440-1746.2009.06018.x
- The paper
- Yokokawa, J., Saito, H., Kanno, Y., Honma, F., Monoe, K., Sakamoto, N., Abe, K., Takahashi, A., Yokokawa, H., & Ohira, H. (2010). Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2009.06018.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.